Project Grant T32AI192234
Award Date 8/10/26
Completion Date 7/31/31
Dollars Obligated $145K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Lexington, KY 40506, USA
Similar Awards
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The University of Kentucky Research Foundation a Project Grant totaling $1,731,364 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on August 29, 2025, with a completion date of July 31, 2029. This biomedical research grant supports investigator-initiated scientific research examining the mechanisms by which microglial interferon-gamma (IFN-γ) production functions as a...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $847,000 in Project Grant funding to The University of Kentucky Research Foundation on July 15, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855). The research, scheduled for completion by June 30, 2027, focuses on identifying the protective roles of CD180 and nucleotide oligomerization domain 1 (NOD1)—two pathogen-associated molecular pattern...
- The National Institute of Allergy and Infectious Diseases, a division of the Department of Health and Human Services, awarded the University of Maryland, Baltimore $312,537 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on September 1, 2026, to support the Mechanisms Integrating Nervous and Immune Systems Training Program (MINISTP). The award funds a two-tiered training curriculum designed to prepare three graduate students and two post-doctoral researchers for up to...
- The National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services National Institutes of Health, awarded the University of Oklahoma Health Sciences Center $233,001 on August 1, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to support an interdisciplinary training program in immunity and microbial infection. The award funds a five-year training program that will provide predoctoral research training to five trainees per...
- The National Institute of Allergy and Infectious Diseases awarded the University of Kentucky Research Foundation $231,000 on August 14, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to investigate the regulation of interferon regulatory factor 7 (IRF7) by an inducible protein phosphatase. The research defines molecular mechanisms by which the phosphatase regulatory subunit 2R1B and its catalytic partners regulate IRF7 phosphorylation and antiviral gene...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The University of Kentucky Research Foundation a Project Grant totaling $423,500 under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective July 1, 2025, through June 30, 2027. This research project investigates the functional roles of chlamydial polymorphic membrane proteins (PMPs), specifically PMPI, during the infectious cycle of Chlamydia trachomatis. The...
- The National Institute of Allergy and Infectious Diseases awarded The University of Kentucky Research Foundation $184,592 on May 22, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to investigate microbial contamination, persistence, and exposure pathways in flood-affected building materials. The research combines field-based floodwater sampling with controlled mesocosm experiments to track microbial colonization and persistence on common building materials...
- The National Institute of Allergy and Infectious Diseases awarded Baylor College of Medicine $452,128 on September 1, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to support research training in infection and immunity. The award funds the Baylor College of Medicine Research Training in Infection and Immunity program, which will train four MD, MD/PhD, or PhD postdoctoral fellows annually for two years of mentored research training. The program provides a...
- The National Institute of Allergy and Infectious Diseases awarded Baylor College of Medicine $201,600 on August 1, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to support an Immunology Training Program. The program establishes a collaboration across three Houston-area institutions—Baylor College of Medicine, University of Texas Health Science Center at Houston, and MD Anderson Cancer Center—to train predoctoral immunology researchers. Four carefully selected...
- The National Institute of Allergy and Infectious Diseases awarded The University of Kentucky Research Foundation $181,103 on June 1, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct mechanistic and transcriptomic modeling comparing aztreonam/avibactam versus aztreonam plus ceftazidime/avibactam in treating Stenotrophomonas maltophilia infections. The research addresses treatment optimization for this multidrug-resistant gram-negative bacterium, which...